Tau levels in platelets isolated from Huntington's disease patients serve as a biomarker of disease severity. - Alpaugh M; Lantero-Rodriguez J; Benedet AL; Manseau U; Boutin M; Maiuri M; Denis HL; Masnata M; Fazal SV; Chouinard S; Rosa-Neto P; Barker RA; et al. (Journal of neurology, 2025)